Liquisolid technology for dissolution rate enhancement or sustained release
- PMID: 20731614
- DOI: 10.1517/17425247.2010.511173
Liquisolid technology for dissolution rate enhancement or sustained release
Abstract
Importance of the field: Most of the drugs that have been invented are of BCS Class II. Therefore, dissolution rate enhancement is the key aspect for absorption of these drugs. Liquisolid technology is very efficient in the dissolution rate enhancement of these drugs. Moreover, use of other polymers such as Eudragit and hydroxypropyl methylcellulose in the liquisolid approach can cause sustained release of drugs. This review focuses on the formulation approaches of liquisolid tablets or compacts along with its fundamental principles.
Areas covered in this review: The review focuses on the developments in liquisolid technology from 1998 to 2009 with in vitro and in vivo performance of the dosage forms prepared using this technology.
What the reader will gain: Benefits of this review include a concise evaluation of this technology by focusing on the scope of future developments to be done using this technique.
Take home message: Liquisolid technology, the next generation of powder solution technology, can be helpful for enhancing dissolution rates of poorly water-soluble drugs as well as effective at sustaining drug release.
Similar articles
-
Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.Colloids Surf B Biointerfaces. 2010 Aug 1;79(1):262-9. doi: 10.1016/j.colsurfb.2010.04.008. Epub 2010 Apr 21. Colloids Surf B Biointerfaces. 2010. PMID: 20451361
-
The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.J Pharm Pharm Sci. 2005 Jan 12;8(1):18-25. J Pharm Pharm Sci. 2005. PMID: 15946594
-
Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.Int J Pharm. 2008 Oct 1;362(1-2):102-8. doi: 10.1016/j.ijpharm.2008.06.022. Epub 2008 Jul 4. Int J Pharm. 2008. PMID: 18647643
-
Drug release from liquisolid systems: speed it up, slow it down.Expert Opin Drug Deliv. 2011 Feb;8(2):191-205. doi: 10.1517/17425247.2011.548801. Epub 2011 Jan 12. Expert Opin Drug Deliv. 2011. PMID: 21222556 Review.
-
Liquisolid Technology: A State-of-the-Art Review on the Current State, Challenges, New and Emerging Technologies for Next Generation.Curr Drug Deliv. 2020;17(9):736-754. doi: 10.2174/1567201817999200729121914. Curr Drug Deliv. 2020. PMID: 32729418 Review.
Cited by
-
Enhancement of the Oral Bioavailability of Fexofenadine Hydrochloride via Cremophor(®) El-Based Liquisolid Tablets.Adv Pharm Bull. 2015 Nov;5(4):569-81. doi: 10.15171/apb.2015.077. Epub 2015 Nov 30. Adv Pharm Bull. 2015. PMID: 26819931 Free PMC article.
-
Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide.Sci Rep. 2021 Jan 14;11(1):1315. doi: 10.1038/s41598-020-79940-5. Sci Rep. 2021. PMID: 33446749 Free PMC article.
-
Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs.Pharmaceutics. 2018 Jun 23;10(3):74. doi: 10.3390/pharmaceutics10030074. Pharmaceutics. 2018. PMID: 29937483 Free PMC article. Review.
-
Modern evaluation of liquisolid systems with varying amounts of liquid phase prepared using two different methods.Biomed Res Int. 2015;2015:608435. doi: 10.1155/2015/608435. Epub 2015 May 17. Biomed Res Int. 2015. PMID: 26075249 Free PMC article.
-
Liquisolid Technique for Solubility Enhancement of Poorly Soluble Drug - A Brief Review.Curr Drug Discov Technol. 2025;22(4):e15701638318659. doi: 10.2174/0115701638318659240923074614. Curr Drug Discov Technol. 2025. PMID: 39377384 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials